Deutsche Bank’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.42K | Sell |
7,520
-39,253
| -84% | -$44K | ﹤0.01% | 3490 |
|
2025
Q1 | $53.8K | Buy |
46,773
+35,546
| +317% | +$40.9K | ﹤0.01% | 3333 |
|
2024
Q4 | $68.6K | Buy |
11,227
+24
| +0.2% | +$147 | ﹤0.01% | 3325 |
|
2024
Q3 | $185K | Buy |
11,203
+354
| +3% | +$5.86K | ﹤0.01% | 2917 |
|
2024
Q2 | $74.5K | Buy |
10,849
+5,302
| +96% | +$36.4K | ﹤0.01% | 3177 |
|
2024
Q1 | $53.5K | Sell |
5,547
-6,155
| -53% | -$59.4K | ﹤0.01% | 3330 |
|
2023
Q4 | $97.2K | Buy |
+11,702
| New | +$97.2K | ﹤0.01% | 3183 |
|
2023
Q3 | – | Sell |
-4,965
| Closed | -$45.8K | – | 3688 |
|
2023
Q2 | $45.8K | Sell |
4,965
-2,158
| -30% | -$19.9K | ﹤0.01% | 3473 |
|
2023
Q1 | $97.9K | Buy |
7,123
+1,795
| +34% | +$24.7K | ﹤0.01% | 3326 |
|
2022
Q4 | $90.6K | Sell |
5,328
-4,434
| -45% | -$75.4K | ﹤0.01% | 3357 |
|
2022
Q3 | $222K | Buy |
9,762
+3,840
| +65% | +$87.3K | ﹤0.01% | 2872 |
|
2022
Q2 | $107K | Buy |
5,922
+1,180
| +25% | +$21.3K | ﹤0.01% | 3469 |
|
2022
Q1 | $127K | Sell |
4,742
-487
| -9% | -$13K | ﹤0.01% | 3459 |
|
2021
Q4 | $154K | Buy |
5,229
+260
| +5% | +$7.66K | ﹤0.01% | 3464 |
|
2021
Q3 | $327K | Sell |
4,969
-160
| -3% | -$10.5K | ﹤0.01% | 3279 |
|
2021
Q2 | $426K | Buy |
5,129
+256
| +5% | +$21.3K | ﹤0.01% | 3305 |
|
2021
Q1 | $373K | Sell |
4,873
-4,221
| -46% | -$323K | ﹤0.01% | 3267 |
|
2020
Q4 | $803K | Buy |
9,094
+5,162
| +131% | +$456K | ﹤0.01% | 2583 |
|
2020
Q3 | $290K | Sell |
3,932
-245
| -6% | -$18.1K | ﹤0.01% | 2954 |
|
2020
Q2 | $304K | Buy |
4,177
+2,421
| +138% | +$176K | ﹤0.01% | 2865 |
|
2020
Q1 | $98K | Sell |
1,756
-74
| -4% | -$4.13K | ﹤0.01% | 3209 |
|
2019
Q4 | $69K | Buy |
+1,830
| New | +$69K | ﹤0.01% | 3683 |
|